Michael Kundi

33PUBLICATIONS
106CO-AUTHORS
Radiation therapyInnate immunityModels of care and place of birthPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jun 25, 2026
Interpretation of Epidemiological Studies on the Relationship Between Mobile Phone Use and Cancer.

|Jul 30, 2025
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix<sup>®</sup>) in VZV Seronegative Immunocompromised Adults.

Andrea Wessely, Ines Zwazl, Melita Poturica

|Apr 02, 2025
Women's satisfaction with breast reconstruction after mastectomy and a survey on the decision process for type of reconstructive surgery.

Ingrid Jelinek, Rupert Koller, Michael Kundi

|Jul 27, 2024
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity.

Joshua Tobias, Peter Steinberger, Joy Wilkinson

|Jul 19, 2024
Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON).

Joshua Tobias, Marina Maglakelidze, Zoran Andrić

|Jul 14, 2024
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19.

Bernhard Kratzer, Pia Gattinger, Doris Trapin

Pageof 6

Frequent Collaborators

7 joint publications

Ursula Wiedermann

5 joint publications

Hanns Moshammer

4 joint publications

Joshua Tobias

4 joint publications

Erika Garner-Spitzer